Enterococcus spp. are Gram-positive, facultative, anaerobic cocci, which are found in the
intestinal flora and, less frequently, in the vagina or mouth. Enterococcus faecalis and …

Vancomycin-resistant enterococci (VRE) are important nosocomial pathogens. Invasive VRE
infections are difficult to treat since common therapeutic options including ampicillin and …

Linezolid, an oxazolidinone antimicrobial agent that acts by inhibiting protein synthesis in a
unique fashion, is used in the treatment of community-acquired pneumonia, skin and soft …

Increases in prevalence of vancomycin-resistant enterococci (VRE) have been documented
globally since its emergence in the 1980s. A SENTRY Antimicrobial Surveillance Program …

Urinary Tract Infections (UTIs) are common outpatient and inpatient infections, often treated
with empirical therapy. Enterococcus spp. is responsible for about 10% of UTIs. This study …

The incidence of vancomycin-resistant Enterococcus faecium isolation was low (≤ 5%) in
German hospitals before 2003. Within the second half of 2003 and the first half of 2004 …

The significant increase of the linezolid-resistant enterococci (LRE) has been observed in
Polish hospitals since 2012 and our study aimed at elucidating the possible reasons for this …

The current drama of antibiotic resistance has revived interest in phage therapy. In response
to this challenge, a phage therapy center was established at our Institute in 2005 which …

This nation–and in fact the world–is currently facing a crisis in the form of a growing
antibacterial drug resistance. In the 60 or so years since the discovery of penicillin …

From relative obscurity, enterococci have become a leading cause of nosocomial infection.
This has been attributed, in part, to the growth in susceptible host populations, increased …